Skip to content

Bee Venom Acupuncture for the Treatment of Chronic Low Back Pain

Clinical Trial to Evaluate the Efficacy of Bee Venom Acupuncture on Chronic Low Back Pain

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01491321
Enrollment
54
Registered
2011-12-14
Start date
2011-04-30
Completion date
2012-03-31
Last updated
2012-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

chronic low back pain, bee venom acupuncture

Brief summary

The purpose of this study is to evaluate the efficacy of bee venom acupuncture on pain intensity, functional status and quality of life of patients with chronic low back pain.

Interventions

Bee Venom 1:20,000 under BVA Increment Protocol Increment Protocol as * 1st week : SC 0.2cc/day, 2days/week * 2nd week : SC 0.4cc/day, 2days/week * 3rd week : SC 0.8cc/day, 2days/week

60 mg/Tab, pers os 1Tab tid, for 3 weeks

PROCEDUREPlacebo

Normal Saline (0.9% NaCl) under NS Increment Protocol Increment Protocol as * 1st week : SC 0.2cc/day, 2days/week * 2nd week : SC 0.4cc/day, 2days/week * 3rd week : SC 0.8cc/day, 2days/week

Sponsors

Kyung Hee University Hospital at Gangdong
CollaboratorOTHER
Kyunghee University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* nonspecific, chronic low back pain over 3 months * Must have LBP of more than VAS 4

Exclusion criteria

* cancer, vertebral fracture, spinal infection, inflammatory spondylitis * spinal operation * radicular pain * other musculoskeletal pain * physicological or mental disorders * allergic history to BV therapy or insect bite

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale for bothersomenessChanges from baseline in VAS at 1 month

Secondary

MeasureTime frame
Visual Analogue Scale for pain intensityChanges from baseline in VAS at 1 month
Disability scores on Oswestry Disability IndexChanges from baseline in ODI at 1 month
Quality of Life scores on EQ-5DChanges from baseline in EQ-5D at 1 month
Depression scores on Beck Depression InventoryChanges from baseline in BDI at 1 month

Countries

South Korea

Contacts

Primary ContactByung-Kwan Seo
seohbk@hanmail.net82-2-440-7482

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026